Our data show that bTAM preferentially express growth factors and cytokines known to promote ovarian cancer growth, progression and relapse, such as CCL18, but also factors, which have previously not been implicated in ovarian cancer progression, e.g. KITLG and complement factors. The gene discussed is CCL18; the disease is ovarian cancer.